nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A preoperative marker panel for the prediction of residual tumor and the decision making for repeat transurethral resection
|
Liu, Wentao |
|
2015 |
33 |
4 |
p. 165.e9-165.e14 1.6499835E16 p. |
artikel |
2 |
Association of urinary bladder paragangliomas with germline mutations in the SDHB and VHL genes
|
Martucci, Victoria L. |
|
2015 |
33 |
4 |
p. 167.e13-167.e20 1.6699998330000001E22 p. |
artikel |
3 |
Bcl-2 predicts response to neoadjuvant chemotherapy and is overexpressed in lymph node metastases of urothelial cancer of the bladder
|
Kiss, Bernhard |
|
2015 |
33 |
4 |
p. 166.e1-166.e8 1.6599998341E10 p. |
artikel |
4 |
Clinically nonmetastatic renal cell carcinoma with sarcomatoid dedifferentiation: Natural history and outcomes after surgical resection with curative intent
|
Merrill, Megan M. |
|
2015 |
33 |
4 |
p. 166.e21-166.e29 1.6599999833999999E31 p. |
artikel |
5 |
Critical appraisal of first-generation renal tumor complexity scoring systems: Creation of a second-generation model of tumor complexity
|
Tobert, Conrad M. |
|
2015 |
33 |
4 |
p. 167.e1-167.e6 1.66998331E8 p. |
artikel |
6 |
Editorial Board
|
|
|
2015 |
33 |
4 |
p. i- 1 p. |
artikel |
7 |
Effect of platelet-derived growth factor-B on renal cell carcinoma growth and progression
|
Wang, Wenling |
|
2015 |
33 |
4 |
p. 168.e17-168.e27 1.6799999998319998E29 p. |
artikel |
8 |
Individualized management of advanced bladder cancer: Where do we stand?
|
Burgess, Earle F. |
|
2015 |
33 |
4 |
p. 187-195 9 p. |
artikel |
9 |
Irreversible electroporation of the porcine kidney: Temperature development and distribution
|
Wagstaff, Peter G.K. |
|
2015 |
33 |
4 |
p. 168.e1-168.e7 1.679998321E9 p. |
artikel |
10 |
Is anatomic complexity associated with renal tumor growth kinetics under active surveillance?
|
Mehrazin, Reza |
|
2015 |
33 |
4 |
p. 167.e7-167.e12 1.66998330000001E14 p. |
artikel |
11 |
Live surgical demonstrations: An endangered species
|
Leavitt, David A. |
|
2015 |
33 |
4 |
p. 159-162 4 p. |
artikel |
12 |
Long-term survival of patients with locally advanced prostate cancer managed with neoadjuvant docetaxel and radical prostatectomy
|
Zhao, Bo |
|
2015 |
33 |
4 |
p. 164.e19-164.e23 1.639836E25 p. |
artikel |
13 |
Masthead
|
|
|
2015 |
33 |
4 |
p. IFC- 1 p. |
artikel |
14 |
Matrix metalloproteinase-9 is required for vasculogenic mimicry by clear cell renal carcinoma cells
|
Lin, Hao |
|
2015 |
33 |
4 |
p. 168.e9-168.e16 1.679999832E18 p. |
artikel |
15 |
MicroRNA-185 inhibits cell proliferation and induces cell apoptosis by targeting VEGFA directly in von Hippel-Lindau–inactivated clear cell renal cell carcinoma
|
Ma, Xin |
|
2015 |
33 |
4 |
p. 169.e1-169.e11 1.6899999998311E13 p. |
artikel |
16 |
Multiparametric magnetic resonance imaging–targeted biopsy for the detection of prostate cancer in patients with prior negative biopsy results
|
Abdi, Hamidreza |
|
2015 |
33 |
4 |
p. 165.e1-165.e7 1.649998351E9 p. |
artikel |
17 |
Natural history of surgically treated high-risk prostate cancer
|
Briganti, Alberto |
|
2015 |
33 |
4 |
p. 163.e7-163.e13 1.629998370000001E15 p. |
artikel |
18 |
Pathologic outcomes for low-risk prostate cancer after delayed radical prostatectomy in the United States
|
Weiner, Adam B. |
|
2015 |
33 |
4 |
p. 164.e11-164.e17 1.63999836E19 p. |
artikel |
19 |
Population-based analysis of salvage radical prostatectomy with examination of factors associated with adverse perioperative outcomes
|
Pearce, Shane M. |
|
2015 |
33 |
4 |
p. 163.e1-163.e6 1.62998371E8 p. |
artikel |
20 |
Prognostic accuracy of Prostate Health Index and urinary Prostate Cancer Antigen 3 in predicting pathologic features after radical prostatectomy
|
Cantiello, Francesco |
|
2015 |
33 |
4 |
p. 163.e15-163.e23 1.6299999837E25 p. |
artikel |
21 |
Renal carcinoma pharmacogenomics and predictors of response: Steps toward treatment individualization
|
Garcia-Donas, Jesus |
|
2015 |
33 |
4 |
p. 179-186 8 p. |
artikel |
22 |
Reprint of: Outcomes in patients with metastatic renal cell cancer treated with individualized sunitinib therapy: Correlation with dynamic microbubble ultrasound data and review of the literature
|
Bjarnason, Georg A. |
|
2015 |
33 |
4 |
p. 171-178 8 p. |
artikel |
23 |
Significance of 4E-binding protein 1 as a therapeutic target for invasive urothelial carcinoma of the bladder
|
Nishikawa, Masatomo |
|
2015 |
33 |
4 |
p. 166.e9-166.e15 1.65999834E17 p. |
artikel |
24 |
Table of Contents
|
|
|
2015 |
33 |
4 |
p. ii-iv nvt p. |
artikel |
25 |
The natural history of renal functional decline in patients undergoing surveillance in the DISSRM registry
|
Castañeda, Crystal V. |
|
2015 |
33 |
4 |
p. 166.e17-166.e20 1.65834E22 p. |
artikel |
26 |
Toward individualized treatment in urologic oncology
|
Rini, Brian I. |
|
2015 |
33 |
4 |
p. 170- 1 p. |
artikel |
27 |
Urokinase-type plasminogen activator receptor (uPAR) expression is associated with T-stage and survival in urothelial carcinoma of the bladder
|
Dohn, Line Hammer |
|
2015 |
33 |
4 |
p. 165.e15-165.e24 1.64999999835E26 p. |
artikel |
28 |
What is the optimal definition of misclassification in patients with very low-risk prostate cancer eligible for active surveillance? Results from a multi-institutional series
|
Gandaglia, Giorgio |
|
2015 |
33 |
4 |
p. 164.e1-164.e9 1.63999998361E11 p. |
artikel |